Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027Aug 20, 2026Novonesis and Novo Nordisk expect results by late 2027 from research on whether microbiome supplements can benefit users of GLP-1 weight-loss drugs.Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027reutersTopic tracking2025-11-06Novonesis Upgrades Organic Sales Growth Guidance, Lowers Margin Expectations2025-11-19Novonesis, Thyssenkrupp Jointly Launch Enzymatic Fat-Splitting Process2026-02-05Novonesis Achieves Renewable Electricity Target for Global Operations2026-02-25Novonesis Expects Sales Growth and Margin Expansion in 20262026-04-16Novonesis Acquires Meihua’s Fermentation Facility in Thailand for $50M2026-08-20Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027FAQWhen does Novonesis expect to release results from its microbiome supplement study conducted with Novo Nordisk?+What type of supplement is Novonesis developing with Novo Nordisk, and how is it intended to be used?+
ChemBrief